饮食干预治疗抑郁相关症状的研究进展

doi:10.3969/j.issn.1674-8115.2024.08.015

上海交通大学学报（医学版） ›› 2024, Vol. 44 ›› Issue (8): 1050-1055.doi: 10.3969/j.issn.1674-8115.2024.08.015

• 综述 • 上一篇

饮食干预治疗抑郁相关症状的研究进展

陈深册¹(), 陈依明¹, 王凡¹, 张梦珂¹, 杨惟杰¹, 吕洞宾¹, 洪武¹^,²^,³()

^1.上海交通大学医学院附属精神卫生中心临床六科，上海 200030
^2.上海市重性精神病重点实验室，上海 200030
^3.上海交通大学中国医院发展研究院心理健康管理研究所，上海 200030

收稿日期:2023-12-08 接受日期:2024-03-28 出版日期:2024-08-28 发布日期:2024-08-27
通讯作者: 洪武 E-mail:chenshentse@163.com;drhongwu@126.com
作者简介:陈深册（1997—），男，中国台湾，硕士生；电子信箱：chenshentse@163.com。
基金资助:
上海市“科技创新行动计划”医学创新研究专项(21Y11905600)

Advances in dietary interventions for the treatment of depression-related symptoms

CHEN Shentse¹(), CHEN Yiming¹, WANG Fan¹, ZHANG Mengke¹, YANG Weichieh¹, LÜ Dongbin¹, HONG Wu¹^,²^,³()

^1.The Sixth Clinical Department, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China
^2.Shanghai Key Laboratory of Psychotic Disorders, Shanghai 200030, China
^3.Mental Health Branch, China Hospital Development Institute, Shanghai Jiao Tong University, Shanghai 200030, China

Received:2023-12-08 Accepted:2024-03-28 Online:2024-08-28 Published:2024-08-27
Contact: HONG Wu E-mail:chenshentse@163.com;drhongwu@126.com
Supported by:
Shanghai Medical Innovation Research Special Project for “Science and Technology Innovation Action Plan”(21Y11905600)

摘要/Abstract

摘要：

抑郁症是一种常见的精神疾病，目前全球有近16%的人群受到抑郁相关症状的影响，而在中国抑郁症患者的诊治率仅有9.5%。抑郁症具有高发病率和低治愈率的特点，如何有效提高其治疗效果是近年来研究的热点。抗抑郁药作为抑郁症的主要治疗方式，存在药物不良反应多和起效慢等缺点，促使人们开始重视抑郁症的非药物治疗。饮食干预是一种改变饮食结构和节律的非药物治疗方式；目前关于饮食干预在精神医学的应用非常广泛，对治疗抑郁症也有一定的效果。近年来的研究证据表明，饮食干预可以通过脑-肠轴相关的进食机制来治疗和改善抑郁症的相关症状。该文综述饮食干预在抑郁症治疗中的多维度探索，包括饮食结构干预、饮食节律干预、肠道菌群的作用等方面，详细介绍饮食干预的方式和涉及的相关机制，希冀为饮食干预治疗抑郁相关症状提供参考。

关键词: 抑郁症, 饮食干预, 非药物治疗, 脑-肠轴, 肠道菌群

Abstract:

Major depressive disorder (MDD) is a common mental illness. Currently, nearly 16% of the global population is affected by depression-related symptoms, while the diagnosis and treatment rate of MDD patients in China is only 9.5%. MDD is characterised by high morbidity and low recovery rate, and how to effectively improve its therapeutic effect has been a hot research topic in recent years. Antidepressants, as the main treatment for MDD, have the disadvantages of many adverse effects and slow onset of action, prompting people to pay attention to the non-pharmacological treatments of MDD. Dietary intervention is a kind of non-pharmacological treatment by changing dietary structures and rhythms; the current application of dietary intervention to psychiatry is very extensive, and it has been proved to be effective in the treatment of depression. Recent research suggests that dietary interventions can treat and ameliorate depressive symptoms by influencing brain-gut axis-related eating mechanisms. This article reviews the multidimensional exploration of dietary interventions in the treatment of depression: dietary structure interventions, dietary rhythm interventions, and the role of intestinal flora. It details the modalities of dietary interventions and the related mechanisms involved, and provides reference for dietary interventions in the treatment of depression-related symptoms.

Key words: major depressive disorder, dietary intervention, non-pharmacological treatment, brain-gut axis, intestinal flora

中图分类号:

R749.4

陈深册, 陈依明, 王凡, 张梦珂, 杨惟杰, 吕洞宾, 洪武. 饮食干预治疗抑郁相关症状的研究进展[J]. 上海交通大学学报（医学版）, 2024, 44(8): 1050-1055.

CHEN Shentse, CHEN Yiming, WANG Fan, ZHANG Mengke, YANG Weichieh, LÜ Dongbin, HONG Wu. Advances in dietary interventions for the treatment of depression-related symptoms[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(8): 1050-1055.

参考文献 41

1	LU J, XU X F, HUANG Y Q, et al. Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study[J]. Lancet Psychiatry, 2021, 8(11): 981-990.
2	OPIE R S, ITSIOPOULOS C, PARLETTA N, et al. Dietary recommendations for the prevention of depression[J]. Nutr Neurosci, 2017, 20(3): 161-171.
3	GŁĄBSKA D, GUZEK D, GROELE B, et al. Fruit and vegetable intake and mental health in adults: a systematic review[J]. Nutrients, 2020, 12(1): 115.
4	JACKA F N, O'NEIL A, OPIE R, et al. A randomised controlled trial of dietary improvement for adults with major depression (the 'SMILES' trial)[J]. BMC Med, 2017, 15(1): 23.
5	PARLETTA N, ZARNOWIECKI D, CHO J, et al. A Mediterranean-style dietary intervention supplemented with fish oil improves diet quality and mental health in people with depression: a randomized controlled trial (HELFIMED)[J]. Nutr Neurosci, 2019, 22(7): 474-487.
6	WINTER S E, BÄUMLER A J. Gut dysbiosis: ecological causes and causative effects on human disease[J]. Proc Natl Acad Sci U S A, 2023, 120(50): e2316579120.
7	LACHANCE L R, RAMSEY D. Antidepressant foods: an evidence-based nutrient profiling system for depression[J]. World J Psychiatry, 2018, 8(3): 97-104.
8	SPOHR L, SOARES M S P, OLIVEIRA P S, et al. Combined actions of blueberry extract and lithium on neurochemical changes observed in an experimental model of mania: exploiting possible synergistic effects[J]. Metab Brain Dis, 2019, 34(2): 605-619.
9	SANDHU K V, SHERWIN E, SCHELLEKENS H, et al. Feeding the microbiota-gut-brain axis: diet, microbiome, and neuropsychiatry[J]. Transl Res, 2017, 179: 223-244.
10	王小咪, 邵云晓, 王小兰, 等. 肠道菌群与抑郁症相关性的研究进展[J]. 现代食品科技, 2023, 39(6): 331-341.
	WANG X M, SHAO Y X, WANG X L, et al. Research progress on correlation between gut mircobiota and depression[J]. Modern Food Science and Technology, 2023, 39(6): 331-341.
11	SHARMA R, SHARMA A, KUMARI A, et al. Consumption of green tea epigallocatechin-3-gallate enhances systemic immune response, antioxidative capacity and HPA axis functions in aged male Swiss albino mice[J]. Biogerontology, 2017, 18(3): 367-382.
12	CATENA-DELL'OSSO M, BELLANTUONO C, CONSOLI G, et al. Inflammatory and neurodegenerative pathways in depression: a new avenue for antidepressant development?[J]. Curr Med Chem, 2011, 18(2): 245-255.
13	NICHOLS A L, BLUMENFELD Z, LUEBBERT L, et al. Selective serotonin reuptake inhibitors within cells: temporal resolution in cytoplasm, endoplasmic reticulum, and membrane[J]. J Neurosci, 2023, 43(13): 2222-2241.
14	MISHRA S, PERSONS P A, LORENZO A M, et al. Time-restricted eating and its metabolic benefits[J]. J Clin Med, 2023, 12(22): 7007.
15	THURFAH J N, CHRISTINE, BAGASKHARA P P, et al. Dietary supplementations and depression[J]. J Multidiscip Healthc, 2022, 15: 1121-1141.
16	PURDEL C, MARGINĂ D, ADAM-DIMA I, et al. The beneficial effects of dietary interventions on gut microbiota-an up-to-date critical review and future perspectives[J]. Nutrients, 2023, 15(23): 5005.
17	HAUPT S, ECKSTEIN M L, WOLF A, et al. Eat, train, sleep-retreat? Hormonal interactions of intermittent fasting, exercise and circadian rhythm[J]. Biomolecules, 2021, 11(4): 516.
18	HOSSEINI E, AMMAR A, JOSEPHSON J K, et al. Fasting diets: what are the impacts on eating behaviors, sleep, mood, and well-being?[J]. Front Nutr, 2023, 10: 1256101.
19	FIRTH J, GANGWISCH J E, BORISINI A, et al. Food and mood: how do diet and nutrition affect mental wellbeing?[J]. BMJ, 2020, 369: m2382.
20	ANTONI R, JOHNSTON K L, COLLINS A L, et al. Effects of intermittent fasting on glucose and lipid metabolism[J]. Proc Nutr Soc, 2017, 76(3): 361-368.
21	LETTIERI-BARBATO D, CANNATA S M, CASAGRANDE V, et al. Time-controlled fasting prevents aging-like mitochondrial changes induced by persistent dietary fat overload in skeletal muscle[J]. PLoS One, 2018, 13(5): e0195912.
22	王凯新, 董晓梦, 苏毅鹏, 等. 肠道菌群与抑郁症关系的研究进展[J]. 吉林大学学报(医学版), 2022, 48(4): 1094-1100.
	WANG K X, DONG X M, SU Y P, et al. Research progress in relationship between gut mircobiota and depression[J]. Journal of Jilin University (Medicine Edition), 2022, 48(4): 1094-1100.
23	LYTE J M. Eating for 3.8×10¹³: examining the impact of diet and nutrition on the microbiota-gut-brain axis through the lens of microbial endocrinology[J]. Front Endocrinol, 2019, 9: 796.
24	BARRATT M J, LEBRILLA C, SHAPIRO H Y, et al. The gut microbiota, food science, and human nutrition: a timely marriage[J]. Cell Host Microbe, 2017, 22(2): 134-141.
25	CHUNG Y E, CHEN H C, CHOU H L, et al. Exploration of microbiota targets for major depressive disorder and mood related traits[J]. J Psychiatr Res, 2019, 111: 74-82.
26	CHEN Z, LI J, GUI S W, et al. Comparative metaproteomics analysis shows altered fecal microbiota signatures in patients with major depressive disorder[J]. Neuroreport, 2018, 29(5): 417-425.
27	TAYLOR A M, HOLSCHER H D. A review of dietary and microbial connections to depression, anxiety, and stress[J]. Nutr Neurosci, 2020, 23(3): 237-250.
28	SLAVICH G M, SACHER J. Stress, sex hormones, inflammation, and major depressive disorder: extending Social Signal Transduction Theory of Depression to account for sex differences in mood disorders[J]. Psychopharmacology, 2019, 236(10): 3063-3079.
29	ASCHBACHER K, O'DONOVAN A, WOLKOWITZ O M, et al. Good stress, bad stress and oxidative stress: insights from anticipatory cortisol reactivity[J]. Psychoneuroendocrinology, 2013, 38(9): 1698-1708.
30	NIKOLOVA V L, SMITH M R B, HALL L J, et al. Perturbations in gut microbiota composition in psychiatric disorders: a review and meta-analysis[J]. JAMA Psychiatry, 2021, 78(12): 1343-1354.
31	GREEN J M, BARRATT M J, KINCH M, et al. Food and microbiota in the FDA regulatory framework[J]. Science, 2017, 357(6346): 39-40.
32	TROUBAT R, BARONE P, LEMAN S, et al. Neuroinflammation and depression: a review[J]. Eur J Neurosci, 2021, 53(1): 151-171.
33	LIANG S, WU X L, HU X, et al. Recognizing depression from the microbiota-gut-brain axis[J]. Int J Mol Sci, 2018, 19(6): 1592.
34	BAMBLING M, EDWARDS S C, HALL S, et al. A combination of probiotics and magnesium orotate attenuate depression in a small SSRI resistant cohort: an intestinal anti-inflammatory response is suggested[J]. Inflammopharmacology, 2017, 25(2): 271-274.
35	DESBONNET L, GARRETT L, CLARKE G, et al. The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat[J]. J Psychiatr Res, 2008, 43(2): 164-174.
36	DESBONNET L, GARRETT L, CLARKE G, et al. Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression[J]. Neuroscience, 2010, 170(4): 1179-1188.
37	CHEUNG S G, GOLDENTHAL A R, UHLEMANN A C, et al. Systematic review of gut microbiota and major depression[J]. Front Psychiatry, 2019, 10: 34.
38	PINTO-SANCHEZ M I, HALL G B, GHAJAR K, et al. Probiotic Bifidobacterium longum NCC3001 reduces depression scores and alters brain activity: a pilot study in patients with irritable bowel syndrome[J]. Gastroenterology, 2017, 153(2): 448-459.e8.
39	KARAKULA-JUCHNOWICZ H, ROG J, JUCHNOWICZ D, et al. The study evaluating the effect of probiotic supplementation on the mental status, inflammation, and intestinal barrier in major depressive disorder patients using gluten-free or gluten-containing diet (SANGUT study): a 12-week, randomized, double-blind, and placebo-controlled clinical study protocol[J]. Nutr J, 2019, 18(1): 50.
40	刘志刚, 贾梦真. 膳食营养干预与脑健康: 调整饮食节律中的“肠-脑”轴机制研究进展[J]. 中国食品学报, 2023, 23(2): 1-13.
	LIU Z G, JIA M Z. Dietary nutrition intervention and brain health: research advances of the gut-brain axis mechanism in regulating diet rhythm[J]. Journal of Chinese Institute of Food Science and Technology, 2023, 23(2): 1-13.
41	LI Y, LV M R, WEI Y J, et al. Dietary patterns and depression risk: a meta-analysis[J]. Psychiatry Res, 2017, 253: 373-382.

[1]	夏西茜, 丁珂珂, 张慧恒, 彭旭飞, 孙昳旻, 唐雅珺, 汤晓芳. 肠道菌群介导胆汁酸影响炎症性肠病的研究进展[J]. 上海交通大学学报（医学版）, 2024, 44(7): 839-846.
[2]	孙晨寅, 吴百川, 张慧凤, 方贻儒, 彭代辉. 体动记录仪评估抑郁症昼夜节律：一项系统综述和meta分析[J]. 上海交通大学学报（医学版）, 2024, 44(5): 606-616.
[3]	杜亚格, 卢言慧, 安宇, 宋颖, 郑婕. 肠道菌群在糖尿病认知功能障碍中的作用机制及靶向干预的研究进展[J]. 上海交通大学学报（医学版）, 2024, 44(4): 494-500.
[4]	杨瑞君, 吕书红, 刘志业, 张新, 刘志浩. 中国5省初中生视屏时间和饮食行为与抑郁症状的关联[J]. 上海交通大学学报（医学版）, 2024, 44(3): 358-364.
[5]	马锦倩, 范翩翩, 郑涛, 张琳, 陈远志, 申剑, 欧阳凤秀. 孕妇肠道、阴道菌群和新生儿胎粪、胎皮脂菌群的相关性研究[J]. 上海交通大学学报（医学版）, 2024, 44(1): 50-63.
[6]	李郡如, 欧阳彦, 谢静远. 肠道菌群在IgA肾病发病与治疗中的作用研究进展[J]. 上海交通大学学报（医学版）, 2023, 43(8): 1044-1048.
[7]	马文琳, 林元杰, 金婷婷, 石薇, 蒋莉华, 赵莉. 初中生自我中心主义与非自杀性自伤的关系研究[J]. 上海交通大学学报（医学版）, 2023, 43(8): 971-976.
[8]	高羽, 殷姗, 庞玥, 梁文懿, 刘玉敏. 大黄对大鼠体内肠道菌群-宿主共代谢作用的影响[J]. 上海交通大学学报（医学版）, 2023, 43(8): 997-1007.
[9]	温亚锦, 何雯, 韩晓, 张晓波. 不同严重程度支气管哮喘儿童肠道菌群差异的探索性分析[J]. 上海交通大学学报（医学版）, 2023, 43(6): 655-664.
[10]	王洁仪, 郑丹, 郑晓皎, 贾伟, 赵爱华. 茶褐素生物学活性及其作用机制的研究进展[J]. 上海交通大学学报（医学版）, 2023, 43(6): 768-774.
[11]	刘芊若, 方子晨, 吴宇涵, 钟羡欣, 国沐禾, 贾洁. 肠道菌群及其代谢产物与妊娠期糖尿病相关性的研究进展[J]. 上海交通大学学报（医学版）, 2023, 43(5): 641-647.
[12]	李偲媛, 和申, 李华芳. 重度抑郁症中自噬通路及其关键标志物的研究进展[J]. 上海交通大学学报（医学版）, 2023, 43(10): 1324-1331.
[13]	王婕, 吴慧, 卢凌鹏, 杨科峰, 祝捷, 周恒益, 姚蝶, 高雅, 冯宇婷, 刘玉红, 贾洁. 妊娠期糖尿病女性肠道菌群的变化特征及其与血糖、血脂和膳食的相关性[J]. 上海交通大学学报（医学版）, 2022, 42(9): 1336-1346.
[14]	卢雨, 王昊, 巴乾. 肠道菌群在肝癌发生发展及治疗中的作用研究进展[J]. 上海交通大学学报（医学版）, 2022, 42(7): 939-944.
[15]	吴侠霏, 方婕, 漆洪波, 余昕烊. 妊娠期糖尿病对C57BL/6J子代成年鼠神经精神功能的影响[J]. 上海交通大学学报（医学版）, 2022, 42(4): 422-432.

饮食干预治疗抑郁相关症状的研究进展

Advances in dietary interventions for the treatment of depression-related symptoms

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 41

相关文章 15

编辑推荐

Metrics